Indications and uses
For relief of skin itching, irritation, redness, flaking and scaling associated with psoriasis and/or seborrheic dermatitis, and to help prevent symptom recurrence
Gold Bond Psoriasis Relief Medicated Multi-Symptom Cream
- Manufacturer
- Chattem, Inc.
- Effective date
- 2025-03-19
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-01 00:57:32
Label at a glance#
ProductGold Bond Psoriasis Relief Medicated Multi-Symptom
Active ingredientSALICYLIC ACID
Label structure8 sections
Dosage and administration
Apply to affected areas one to four times daily or as directed by a doctor
Label contents#
Full prescribing information#
SPL UNCLASSIFIED SECTION
Gold Bond Psoriasis Relief Medicated Multi-Symptom Cream
Drug Facts
Active ingredient
Salicylic acid 3%
Purposes
Psoriasis, Seborrheic Dermatitis
Uses
For relief of skin itching, irritation, redness, flaking and scaling associated with psoriasis and/or seborrheic dermatitis, and to help prevent symptom recurrence
Warnings
For external use only
Ask a doctor before use if
- condition covers a large area of the body
When using this product
- avoid contact with the eyes. If contact occurs, rinse eyes thoroughly with water.
Stop use and ask a doctor if
- condition worsens or does not improve after regular use of this product as directed
Keep out of reach of children.
If swallowed, get medical help or contact a Poison Control Center immediately.
Directions
Apply to affected areas one to four times daily or as directed by a doctor
Inactive ingredients
water, hydroxyethyl urea, petrolatum, aminomethyl propanol, glycerin, dimethicone, gluconolactone, steareth-21, jojoba esters, glyceryl stearate, stearyl alcohol, aloe barbadensis leaf juice, hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, butyrospermum parkii (shea) butter extract, methyl gluceth-20, 7-dehydrocholesterol, bisabolol, ceteareth-25, zea mays (corn) oil, zingiber officinale (ginger) root extract, ceramide NP, hydrolyzed jojoba esters, cetearyl alcohol, stearamidopropyl PG-dimonium chloride phosphate, magnesium ascorbyl phosphate, panthenol, tocopheryl acetate, ceramide EOP, pentylene glycol, ceramide EOS, bis-lauryl cocaminopropylamine/HDI/PEG-100 copolymer, cholesterol, propylene glycol, caprooyl phytosphingosine, polysorbate 60, ceramide NS, cetyl alcohol, isohexadecane, ethylhexylglycerin, 4-t-butylcyclohexanol, ceramide AP, EDTA, behenic acid, butylene glycol, caprooyl sphingosine, methylparaben, tocopherol
PRINCIPAL DISPLAY PANEL
Gold Bond Psoriasis Relief Medicated Multi-Symptom Cream
Net wt 4 oz (113 g)
DailyMed RxNorm Mappings#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 41167-0413-2 | Gold Bond Psoriasis Relief Medicated Multi-Symptom | 113 g in 1 TUBE | CREAM | 113 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 41167-0413 | GOLD BOND PSORIASIS RELIEF MEDICATED MULTI-SYMPTOM (SALICYLIC ACID) CREAM [CHATTEM, INC.] | 1 | Current NDC, 1 package rows | 20250322_e8479bbc-5f49-41f2-851e-a93543516639.zip |
Products#
Every source-derived product name is available through these pages.
- Gold Bond Psoriasis Relief Medicated Multi-Symptom
- Salicylic Acid
- WATER
- HYDROXYETHYL UREA
- PETROLATUM
- AMINOMETHYLPROPANOL
- GLYCERIN
- DIMETHICONE
- GLUCONOLACTONE
- STEARETH-21
- HYDROGENATED JOJOBA OIL, RANDOMIZED
- GLYCERYL STEARATE
- STEARYL ALCOHOL
- ALOE VERA LEAF
- HYDROXYETHYL ACRYLATE/SODIUM ACRYLOYLDIMETHYL TAURATE COPOLYMER (45000 MPA.S AT 1%)
- SHEA BUTTER
- METHYL GLUCETH-20
- 7-DEHYDROCHOLESTEROL
- LEVOMENOL
- CETEARETH-25
- CORN OIL
- GINGER
- CERAMIDE NP
- HYDROLYZED JOJOBA ESTERS (ACID FORM)
- CETEARYL ALCOHOL
- STEARAMIDOPROPYL PG-DIMONIUM CHLORIDE PHOSPHATE
- MAGNESIUM ASCORBYL PHOSPHATE
- PANTHENOL
- ALPHA-TOCOPHEROL ACETATE
- PENTYLENE GLYCOL
- CERAMIDE EOS
- CHOLESTEROL
- PROPYLENE GLYCOL
- CAPROOYL PHYTOSPHINGOSINE
- POLYSORBATE 60
- CERAMIDE NS
- CETYL ALCOHOL
- ISOHEXADECANE
- ETHYLHEXYLGLYCERIN
- 4-T-BUTYLCYCLOHEXANOL
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 41167-0413 | 41167-0413-2 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gold Bond Psoriasis Relief Medicated Multi-Symptom | SALICYLIC ACID | Chattem, Inc. | e8479bbc-5f49-41f2-851e-a93543516639 | 2025-03-19 | Warnings | 41167-0413-2 41167-0413 41167041302 a4965a60-d05e-45c3-8f0c-0e39f5efbf6e e8479bbc-5f49-41f2-851e-a93543516639 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.